MedWatch

Chemometec experiments with diagnostics and develops new cancer test

Danish Chemometec joins forces with research team from University of Copenhagen to develop a method to diagnose cancer early. The project is still "on a very early stage" but can potentially pave the way to a whole new business area for the medtech firm.

Martin Glensbjerg, COO in Chemometec. | Foto: Chemometec

Danish medtech company Chemometec, specialized in development of cell analysis instruments, is working on a research project that could potentially unlock the door to a new business area.

Chemometec has joined forces with Danish researcher Birgitte Regenberg and her team from University of Copenhagen to develop a new test for diagnosing cancer.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

EU-lande blåstempler nye beføjelser til agentur

Det europæiske center for sygdomsforebyggelse og -kontrol, ECDC, får nu nye muskler til kontrol og netværksopbygning i kampen mod fremtidens epidemier. ”Dagens aftale er lig med state-of-the-art overvågning,” siger EU-topfolk.

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier